Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Hasbro Shares Hit Record High on Gaming Division Success

Dieter Jaworski by Dieter Jaworski
August 23, 2025
in Stocks
0
Hasbro Stock
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

The iconic toy manufacturer Hasbro is experiencing a remarkable resurgence, with its stock reaching unprecedented levels. This surge is primarily fueled by the exceptional performance of its gaming division, even as the company’s traditional toy business faces ongoing challenges. The critical question for investors is whether the growth from brands like Magic: The Gathering can single-handedly sustain this upward trajectory.

Impressive Quarterly Results Exceed Forecasts

Hasbro’s second-quarter 2025 financial report delivered a stunning performance that significantly outpaced market expectations. The company posted revenue of $980.8 million, surpassing projections by a substantial 12 percent. Even more impressive was the earnings per share figure of $1.30, which dramatically exceeded the anticipated $0.78. This outstanding performance was largely driven by the Wizards of the Coast segment, home to powerhouse gaming franchises including Magic: The Gathering and Dungeons & Dragons, which continue to generate substantial revenue.

Market Experts Revise Price Targets Upward

The stronger-than-anticipated results triggered a series of upgrades from financial institutions. UBS raised its price objective to $88, highlighting the company’s strengths in the gaming sector. Citi expressed even greater optimism with a $91 target, while Goldman Sachs had already upgraded the stock to “Buy” with an $85 target in June. Morgan Stanley followed suit by reaffirming its “Overweight” rating. The current range of price targets now extends to $95, demonstrating strong confidence from market analysts.

Should investors sell immediately? Or is it worth buying Hasbro?

Beyond the share price appreciation, Hasbro maintains its commitment to shareholder returns through a consistent dividend policy. The annual distribution of $2.80 per share provides an attractive yield of 3.5 percent. However, recent insider trading activity reveals a more nuanced picture: two senior executives, including the CEO of Hasbro Gaming, sold significant stock holdings in late August at prices around $79 per share.

The central challenge for Hasbro remains its ability to sustain growth in its high-margin gaming business while simultaneously stabilizing its traditional toy operations. Market sentiment appears positive, with the stock trading just slightly below its all-time peak.

Ad

Hasbro Stock: Buy or Sell?! New Hasbro Analysis from February 7 delivers the answer:

The latest Hasbro figures speak for themselves: Urgent action needed for Hasbro investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Hasbro: Buy or sell? Read more here...

Tags: Hasbro
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
Remitly Global Stock

Remitly's Market Paradox: Record Profits Amid Executive Share Sales

Edgewell Personal Care Stock

Edgewell Personal Care: A Strategic Pivot Amidst Market Challenges

Idex Stock

Idex Shares Show Fragile Recovery Amid Technical and Fundamental Pressures

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com